Management of lymphoma survivor patients in Italy: an evaluation by Fondazione Italiana Linfomi.

Carla Minoia; Alessia Bari; Luca Nassi; Rita Banzi; Chiara Gerardi; Valentina Lenti; Marco Calabrese; Michele Spina; Attilio Guarini

doi:10.1177/0300891620905649

Management of lymphoma survivor patients in Italy: an evaluation by Fondazione Italiana Linfomi.

Carla Minoia, Alessia Bari, Luca Nassi, Rita Banzi, Chiara Gerardi, Valentina Lenti, Marco Calabrese, Michele Spina, Attilio Guarini

Research output: Contribution to journal › Article › peer-review

Abstract

Several outpatient models for the follow-up of cancer survivors have been developed worldwide. A multidisciplinary approach is often necessary to guarantee the best monitoring of long-term toxicities. Guidelines also indicate a close education on healthy lifestyles. In this context, we have analyzed the Italian follow-up modalities of lymphoma survivors, with the aim to have a starting line to hypothesize and plan the best model for Italian hematology centers.

Original language	English
Pages (from-to)	91-94
Number of pages	4
Journal	Tumori
Volume	107
Issue number	1
DOIs	https://doi.org/10.1177/0300891620905649
Publication status	Published - Feb 2021

Keywords

cancer survivor
epidemiology and prevention
Lymphoma

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1177/0300891620905649

Fingerprint Dive into the research topics of 'Management of lymphoma survivor patients in Italy: an evaluation by Fondazione Italiana Linfomi.'. Together they form a unique fingerprint.

Cite this

@article{de3a1294c5e542d3a314cd04e2887a86,

title = "Management of lymphoma survivor patients in Italy: an evaluation by Fondazione Italiana Linfomi.",

abstract = "Several outpatient models for the follow-up of cancer survivors have been developed worldwide. A multidisciplinary approach is often necessary to guarantee the best monitoring of long-term toxicities. Guidelines also indicate a close education on healthy lifestyles. In this context, we have analyzed the Italian follow-up modalities of lymphoma survivors, with the aim to have a starting line to hypothesize and plan the best model for Italian hematology centers.",

keywords = "cancer survivor, epidemiology and prevention, Lymphoma",

author = "Carla Minoia and Alessia Bari and Luca Nassi and Rita Banzi and Chiara Gerardi and Valentina Lenti and Marco Calabrese and Michele Spina and Attilio Guarini",

year = "2021",

month = feb,

doi = "10.1177/0300891620905649",

language = "English",

volume = "107",

pages = "91--94",

journal = "Tumori",

issn = "0300-8916",

publisher = "SAGE Publications Ltd",

number = "1",

}

TY - JOUR

T1 - Management of lymphoma survivor patients in Italy: an evaluation by Fondazione Italiana Linfomi.

AU - Minoia, Carla

AU - Bari, Alessia

AU - Nassi, Luca

AU - Banzi, Rita

AU - Gerardi, Chiara

AU - Lenti, Valentina

AU - Calabrese, Marco

AU - Spina, Michele

AU - Guarini, Attilio

PY - 2021/2

Y1 - 2021/2

N2 - Several outpatient models for the follow-up of cancer survivors have been developed worldwide. A multidisciplinary approach is often necessary to guarantee the best monitoring of long-term toxicities. Guidelines also indicate a close education on healthy lifestyles. In this context, we have analyzed the Italian follow-up modalities of lymphoma survivors, with the aim to have a starting line to hypothesize and plan the best model for Italian hematology centers.

AB - Several outpatient models for the follow-up of cancer survivors have been developed worldwide. A multidisciplinary approach is often necessary to guarantee the best monitoring of long-term toxicities. Guidelines also indicate a close education on healthy lifestyles. In this context, we have analyzed the Italian follow-up modalities of lymphoma survivors, with the aim to have a starting line to hypothesize and plan the best model for Italian hematology centers.

KW - cancer survivor

KW - epidemiology and prevention

KW - Lymphoma

UR - http://www.scopus.com/inward/record.url?scp=85081668146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081668146&partnerID=8YFLogxK

U2 - 10.1177/0300891620905649

DO - 10.1177/0300891620905649

M3 - Article

C2 - 32116159

AN - SCOPUS:85081668146

VL - 107

SP - 91

EP - 94

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 1

ER -